ACE2 and COVID-19: When we analyzed the result by the patient group instead of by presence of an ACE2 antibody, we found that ACE2 activity is significantly increased when plasma or serum from hospitalized patients with acute COVID-19 (Inpatient+) is added to the activity assay.